These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2589372)

  • 21. [Value of cefotaxime in gram-negative bacterial meningitis. Apropos of 3 developmental forms in neonates and infants].
    Sarlangue J; Megraud F; Nelson JR; Martin C
    Pediatrie; 1984 Dec; 39(8):645-51. PubMed ID: 6100207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.
    Peacock JE; Pegram PS; Weber SF; Leone PA
    Am J Med; 1989 Nov; 87(5A):185S-190S. PubMed ID: 2686421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Designing appropriate therapy in the treatment of gram-negative bacillary meningitis.
    Corrado ML; Gombert ME; Cherubin CE
    JAMA; 1982 Jul; 248(1):71-4. PubMed ID: 7087095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose intravenous ciprofloxacin in febrile neutropenic patients.
    Johnson PR; Yin JA; Tooth JA
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():101-7. PubMed ID: 2292537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin in experimental Pseudomonas aeruginosa meningitis in rabbits.
    Hackbarth CJ; Chambers HF; Stella F; Shibl AM; Sande MA
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():65-9. PubMed ID: 3100492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of serious infections with intravenous ciprofloxacin. French Multicenter Study Group.
    Modai J
    Am J Med; 1989 Nov; 87(5A):243S-247S. PubMed ID: 2686426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of intravenous ciprofloxacin in difficult-to-treat infections.
    Giamarellou H; Galanakis N
    Am J Med; 1987 Apr; 82(4A):346-51. PubMed ID: 3555059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-neurosurgical and spontaneous gram-negative bacillary meningitis in adults.
    Mancebo J; Domingo P; Blanch L; Coll P; Net A; Nolla J
    Scand J Infect Dis; 1986; 18(6):533-8. PubMed ID: 3810047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pefloxacin treatment of meningitis caused by gram-negative bacteria.
    Segev S; Barzilai A; Rosen N; Joseph G; Rubinstein E
    Arch Intern Med; 1989 Jun; 149(6):1314-6. PubMed ID: 2730249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intraventricular antimicrobial therapy in postneurosurgical Gram-negative bacillary meningitis or ventriculitis: a hospital-based retrospective study.
    Wang JH; Lin PC; Chou CH; Ho CM; Lin KH; Tsai CT; Wang JH; Chi CY; Ho MW
    J Microbiol Immunol Infect; 2014 Jun; 47(3):204-10. PubMed ID: 23201321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous/oral ciprofloxacin therapy of infections caused by multiresistant bacteria.
    Neu HC; Davidson S; Briones F
    Am J Med; 1989 Nov; 87(5A):209S-212S. PubMed ID: 2511758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ciprofloxacin and loperamide in the treatment of bacillary dysentery.
    Murphy GS; Bodhidatta L; Echeverria P; Tansuphaswadikul S; Hoge CW; Imlarp S; Tamura K
    Ann Intern Med; 1993 Apr; 118(8):582-6. PubMed ID: 8452323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis].
    Decazes JM; Meulemans A; Bure A; Laisne MJ; Modai J
    Presse Med; 1984 Feb; 13(5):261-4. PubMed ID: 6229775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post neurosurgery Gram-negative bacillary meningitis.
    Klastersky J; Mombelli G; Coppens L; Daneau D; Brihaye J
    J Infect; 1981 Mar; 3(1 Suppl):45-51. PubMed ID: 7185952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.
    Levine DP; McNeil P; Lerner SA
    Am J Med; 1989 Nov; 87(5A):160S-163S. PubMed ID: 2686416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy and levels of ciprofloxacin in tissue in patients with soft tissue infection.
    Licitra CM; Brooks RG; Sieger BE
    Antimicrob Agents Chemother; 1987 May; 31(5):805-7. PubMed ID: 3606079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aminoglycoside therapy of gram-negative bacillary meningitis.
    Kaiser AB; McGee ZA
    N Engl J Med; 1975 Dec; 293(24):1215-20. PubMed ID: 1102982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.
    Chayakul P; Krisanapan S; Kalnauwakul S
    J Med Assoc Thai; 1993 Jan; 76(1):35-40. PubMed ID: 8228692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic treatment of cutaneous infections. A comparative study of ciprofloxacin and cefotaxime.
    Parish LC; Asper R
    Am J Med; 1987 Apr; 82(4A):227-9. PubMed ID: 3555041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.